Diagnostics Medical Devices Physics-Informed Autoencoder For Non-Invasive Prediction Of Tissue Composition From MRI Data Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Machine Learning/Artificial Intelligence Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Antibody-Polymer Conjugates For Engaging T Cells To Destroy Cancer Cells An antibody linked to a polymer that connects T cells to cancer cells enabling broad cancer targeting and effective tumor cell killing without needing… Desired Partnership: Co-development, Licensing IP: Patent Pending
Research Tools Therapeutics Nucleic Acid Enrichment And Sequencing Method For Detecting Off-Target Base Editing Events Inrich-seq is a new method that selectively enriches and sequences inosine-containing DNA or RNA, enabling highly sensitive, genome-wide detection of off-target effects from adenine… Interests: Drug Screening, Gene Therapy Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Therapeutics A Biomarker Analysis Platform For Predicting Immunotherapy Response And Survival In Cancer Patients Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Biomarker, Immunotherapy, Oncology Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Mesenchymal Stem Cell And Exosome-Based Therapeutics For Restoring Ovarian Function In Premature Ovarian Insufficiency Therapeutic strategy using human mesenchymal stem cells or their exosomes to restore ovarian function and fertility in premature ovarian insufficiency by promoting cell growth,… Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Nanoparticles Containing Multiple Cleavable Prodrugs For Cancer Therapy Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Chemical Synthesis, Combination Therapy, Drug Delivery Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Medical Devices Automated Microfluidic Platform For High-Throughput 3D Cell Culture, Dynamic Stimulation, And Single-Cell Analysis Automated microfluidic platform enabling high-throughput, precise 3D cell and organoid culture, drug screening, and single-cell analysis, allowing real-time monitoring and dynamic control of cellular… Interests: Cell Line Desired Partnership: Co-development, Licensing IP: Patent Issued
Therapeutics Small Molecule Therapeutics For Inhibiting Carotid Body Hypersensitivity To Treat Sleep-Related Breathing Disorders New compounds that inhibit an enzyme to reduce hydrogen sulfide in the carotid body, helping to normalize breathing and prevent sleep apnea by targeting… Interests: Small Molecules Desired Partnership: Co-development, Licensing IP: Patent Issued
Therapeutics Lymphangiogenesis For Therapeutic Immunomodulation A vaccine platform that uses engineered lymphangiogenesis factors and antigens to stimulate lymphatic endothelial cells, creating strong, long-lasting immune memory or tolerance with fewer… Interests: Biologics, Immunotherapy, Oncology Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics A Gene-Modified T Cell Platform For Spatially Controlled Therapeutic Protein Delivery In Response To Radiation Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Interests: Immunooncology, Oncology, Oncology Radiotherapy Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Research Tools Ligand-Directed Photo-Proximity Labeling Technology For Profiling And Detecting Cancer Biomarker Interactions In Live Cells Burn injuries are among the most devastating of all injuries and are the fourth most common type of trauma worldwide. In the United States,… Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics A Non-Hormonal Therapeutic Platform For Targeting M6A Regulators To Treat Uterine Fibroids A non-hormonal therapeutic strategy for uterine fibroids targeting the upregulated m6A regulator METTL3 employing small molecule inhibitors thereby reducing fibroid cell proliferation and increasing… Interests: Reproductive Health, Small Molecules, Urology Desired Partnership: Co-development, Licensing IP: Patent Pending
